To Get Help Now
Click Here
 
Today's Date:

New Jersey Mom Joins Yaz Litigation After Teen’s Death

AddThis Social Bookmark Button

Michelle Pfleger died at the age of 18 after a blood clot lodged in her lung, caused her to go into cardiac arrest as she made her way to class at Elon University in North Carolina, according to a report from NJ.com. Her mother, Joan Cummins of New Jersey, has joined thousands of others are alleging Bayer did not provide adequate warnings about the health risks associated with Yaz, and they are blaming the drug for causing blood clots, heart attacks, strokes and, in some cases, sudden deaths.

Yaz and its predecessor, Yasmin, are part of a group of oral contraceptives that contain a combination of the estrogen ethinyl estradiol and drospirenone, a synthetic hormone. Both drugs were made by Berlex Labs, which was acquired in 2006 by Bayer Healthcare.

The FDA approved Yasmin in 2001, and five years later they allowed Berlex to begin selling Yaz, another version of the drug. The two pills quickly became top-sellers, generating hundreds of millions in annual sales for Bayer.

There have already been more than 900 lawsuits have been filed in Bergen County — one of four courts where the mass
tort litigation will be heard. Hundreds of other cases are filed in courts in Philadelphia, California and Illinois.

The family of a teenager who dies after using the contraceptive pill Yaz have joined thousands of others.
Michelle Pfleger died at the age of 18 after a blood clot lodged in her lung, caused her to go into cardiac arrest as she made her way to class at Elon University in North Carolina

Her mother, Joan Cummins and thousands of others are alleging Bayer did not provide adequate warnings about the health
risks associated with Yaz, and they are blaming the drug for causing blood clots, heart attacks, strokes and, in some cases, sudden deaths.

Yaz and its predecessor, Yasmin, are part of a group of oral contraceptives that contain a combination of the estrogen ethinyl estradiol and drospirenone, a synthetic hormone.

Both drugs were made by Berlex Labs, which was acquired in 2006 by Bayer Healthcare.

The FDA approved Yasmin in 2001, and five years later they allowed Berlex to begin selling Yaz, another version of the
drug.

The two pills quickly became top-sellers, generating hundreds of millions in annual sales for Bayer. Last year, annual sales of Yaz reached $361 million, according to Pennsylvania-based SDI Health, which tracks sales of prescription drugs. Annual sales of Yasmin have declined since 2008 when the drug generated $329 million.

There have already been more than 900 lawsuits have been filed in Bergen County — one of four courts where the mass tort litigation will be heard. Hundreds of other cases are filed in courts in Philadelphia, California and Illinois.

sideeffectslawsuitsnews.com disclaimer: This article: New Jersey Mom Joins Yaz Litigation After Teen’s Death was posted on Wednesday, July 13th, 2011 at 7:18 pm at sideeffectslawsuitsnews.com and is filed under Uncategorized.

« »